Transcript Slide 1

Economic
Development
Advisory
Group
March
2012
Meeting
Agenda
I.
New Member Introduction – Bryan Jamele, MLSC
II.
BioLeads Update
III. MLSC Tax Incentives Award
IV. MassBio Annual Meeting Preview
- MassBio Leading Edge Award
- BioMFG Panel
V.
BIO 2012 Preview
VI. MFG Survey update - Don Walsh
VII. Review of Governor's "Choosing to Compete in the 21st Century" plan
2
I. New Member Introduction
Bryan Jamele (Ja-Mel-y)
Governmental Relations and Policy Manager,
Massachusetts Life Sciences Center
3
II. BioLeads Review
The team
considers wins
those leads that
are positively
resolved in which
one or more
team members
took an active
roll.
The BioLeads team (MassBio, MLSC, MOBD, MOITI, MassEcon) oversaw
94 qualified company leads in 2011 through November. Of these leads, 21
became "wins", with companies located to or expanding in Massachusetts, 9
were "positive resolutions", with companies resolving issues with limited or no
team assistance, and 14 leads were "tabled", with leads ending or not being
positively resolved. Currently, there are 43 active leads.
Several wins include foreign companies that opened operations in
Massachusetts. The wins in 2011 have included:
Avaxia, Acebright (China), AB Biotherapautics (Spain), Curementa,
Diagnostics for All, HighRes Biosolutions, Pharyx, En Vivo, IDBS (UK), T2
Biosystems, Screen Cell, Prism Ideas (UK), Radisens Diagnostics (Ireland),
Variation Technologies (Canada), DPS Biometrics, Vertex, Early Sense
(Israel), Ipsen Biomeasure, Sony DADC (Japan), and Izon (New Zealand).
Collectively, these companies plan 408 net new jobs in Massachusetts by the
close of 2012.
4
III. LSI Tax Incentives
$21.2 million to 28 companies
$24,486 per job created
Types of Benefits
Refundable 10% Investment Tax Credit
Refundable Research Tax Credit
Job Creation Tax Credit – New!
Special Sales Tax Exemption
Extension of Let Operating Losses to 15 years
Refundable FDA User fee Credit
Life Sciences Research Credit
Deduction for Orphan Drug Clinical Testing
Elimination of Sales Factor Throwback
Construction Sales Tax Exemption
http://www.masslifesciences.com/index.html
5
IV. MassBio Annual Meeting
Monday, March 26 – Tuesday, March 27 at Sonesta Cambridge
The goals of the Annual Meeting are to Connect, Collaborate,
and Innovate:
1. Discuss and debate the most relevant science and business
topics driving industry’s innovation challenges
2. Promote collaboration with industry scientists, CSOs and other
life sciences leaders to enhance scientific and business
understanding, augment deal flow and connections.
3. Forge new scientific and business relationships
4. Build the network of up-and-coming academic scientists
6
http://www.massbio.org/events/calendar/1342-massbio_annual_meeting/event_detail
IV. Annual Meeting: Leading Edge Award
Leading Edge Award Presentation - Monday, March 26th at 3:20 PM
Summary of Award Scoring
• significant contributions made to further Massachusetts as a life sciences hub.
• Innovators/innovations helped advance biotech and life sciences in these areas.
• improved the competitiveness of Massachusetts as a destination for the life sciences .
Honorable
Mentions
Pfizer Center for Therapeutic Innovation (CTI)
Alexandria Real Estate Equities
Massachusetts Biomedical Initiatives
Shire HGT
Cummings Properties
Ginkgo Bioworks
Venture Development Center – UMass-Boston
Addgene
3
4
4
5
6
6
6
7
Winner
7
IV. Annual Meeting: BioMFG Panel
What will biomanufacturing look like in 2025?
Turns out that New England is a global leader in biomanufacturing. The panel will focus on
the key differentiators that set biomanufacturing here apart and discuss what the sector will
look like in the next decade. As the industry shifts to different kinds of products, such as
combination products, cell therapies and nanomaterials. History with the molecule will be
more important than ever in delivering quality, compliant, and successful products. More
than ever, having manufacturing assets proximate to core research will affect success at the
drug development transition point and beyond.
Moderator: Mickey Koplove
Panelists:
• Michael Cicio, VP Operations and Site Manager, New England Operations, Lonza
Biologics
• Scott Lauder, Senior Director and Global Head, Protein and Cell Sciences, EMD
Serono
• Carl W. Lawton, Director, Massachusetts Biomanufacturing Center, UMass Lowel
• Ralph Lambalot, Vice President, Biologics Development & Manufacturing Launch,
Abbott
8
V. BIO 2012 - Pre-Bio Activities
Friday, June 15, MassBio will host
networking sessions, an orientation lunch,
and industry cluster tours. Morning
networking will include discussions
featuring panelists from local industry and
the academic and hospital-based research
communities. After lunch, attendees will be
provided tours of the area’s biotechnology
supercluster. The day will conclude with a
reception at Tech Square in Cambridge.
Sunday, June 17, Massachusetts Global
Gateway Welcome Reception at the New
England Aquarium in Boston. The event will
feature national “meet-up” stations,
facilitating networking in an informal
setting. International sponsors will also be
featured as speakers during “national
toasts” which will occur throughout the
event. This event, hosted by MassBio and
MOITI, will provide attendees an
opportunity to make helpful connections in
a relaxed and fun atmosphere before the
business of the BIO International
Convention begins.
Tour I: Broad Institute, Biogen Idec
Tour II: Millennium, Vertex
Tour III: Genzyme, Center for Life
Sciences, Pfizer CTI
New England Aquarium
9
V. BIO 2012: Massachusetts Pavilion
Mass
Pavilion
Booth 137: 7,700 square feet at front of convention hall
Summer
Street (main)
entrance is
this way
V. BIO 2012: Massachusetts Pavilion Branding
Pavilion brand and logo
MA is a leader in all stages of the life science lifecycle
Ideas – People, Academia & Hospitals
Early Stage – Start Ups, Entrepreneurial culture
Drug Development, supportive eco-system
Manufacturing
Collaboration – government, non-profits, industry
Pavilion Floor Plan
There are 5
storyboard panels in
the Pavilion.
Each one of these
panels is doublesided.
A patient’s photo will
be featured on the
front of each
storyboard, along with
text that will tell their
story and that will
highlight their
connection to the
state.
On the reverse side of
each patient story, we
will highlight the role
that MA companies
play in the life science
“lifecycle”.
Patient Story Boards
Patient photo will be
wrapped in graphic
“DNA Strand” that will
highlight connections
this patient has to MA:
for example, what
company
manufactures the
therapy that has
treated his/her
disease; the
hospital/center where
he/she has been
treated; and who was
responsible for the
research and
development of the
drug.
Other connections may be
highlighted.
Some sponsors will be
featured on either side with
logo and text.
*Mock-up/draft version of patient story, for viewing purposes only.
Currently in draft by 451 Marketing
Pavilion Floor Plan
On both sides of our
10’ x 20’ LED screen
we will highlight
aspects of our cluster
that make us THE
.
Premier place
in the
world for
biotechnology:
-
Cities and towns that
support the cluster
- Workforce development
information
- Statistics highlighting
MA strengths such as:
NIH-funding to both
hospitals and academic
institutions; VC funding;
employment numbers;
drugs in the pipeline.
- Timeline of the industry
in MA.
Left Side of the Tall Wall in Pavilion
Workforce Development
Statistics
Timeline
*Mock-up/draft version of patient story, for viewing purposes only.
Currently in draft by 451 Marketing
Right Side of the Tall Wall in Pavilion
Timeline Part 2
Cities and Towns
*Mock-up/draft version of patient story, for viewing purposes only.
Currently in draft by 451 Marketing
Conference Rooms
Conference Rooms
will be available for
use by Pavilion
Sponsors and
Partners to hold their
partnering meetings.
Meeting spaces are
located behind the tall
walls in the Pavilion.
VI. Manufacturing Survey
Don Walsh
18
VII. Choosing to Compete in the 21st Century
Released by Governor Patrick in December
5 Steps Toward a More Competitive Economy
1.
2.
3.
4.
5.
Advance programs for “Middle-Skill” jobs
Support Innovation and Entrepreneurship
Regional Development Focus
Increase Ease of Doing Business
Address Cost Competitiveness
19
Compete - continued
1. Advance programs for “Middle-Skill” jobs
- Clarify leadership for workforce training
- “Stackable Opportunities” e.g. internships, apprenticeships
- Evaluation and accountability of system
- Support success like Workforce Training Fund
- Regional focus
- Increase range of population receiving training
- Best practice STEM programs, emphasize hands-on
programs
2. Innovation & Entrepreneurship
- Identify 3-5 areas of global innovation excellence
- Increase 20% funding of mentoring, incubator, and
accelerator programs
- Increase internships by 20%
- Incentivize Gateway Cities
- Raise profile of advanced MFG
- Systemic effort to locate ancillary activities of companies in20
state
Compete - continued
3. Regional Development Focus
- Identify priority development areas
- Target state investments at such areas
- Create regional CEO for Development teams
- 10% of communities develop strategies
- Establish regional best practice academies
4. Increase Ease of Doing Business
- Ongoing state regulatory review
- Establish regulatory ombudsman
- Business advisory group on regulations
- Continue to consolidate economic development agencies
- Make regional organizations true partners
- Increase state Ambassadors programs
- Increase host activities
- Showcase development ready sites
21
Compete - continued
5. Cost Competitiveness
- Move away fro fee-for-service health care to global
payments
- Enhance consumer choice in health care
- Use e-health technologies to lower costs
- Diversify energy portfolio
- Pursue renewables for generation to grid
- Review of UI system
- Simplify tax structure
- Shift to non-tax business incentives (training, infrastructure,
financing) to support development
- Establish accountability for tax-based incentives
22
VIII. 2012 EDAG Scehdule
• Wed. June 6th at MassBio
• Wed. September 12 at MassBio
• Wed. Dec. 5th at MassBio
23